FDA informs health care providers, facilities and patients about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical

January 23, 2020 FDA

FDA is issuing a safety communication informing health care providers, facilities and patients about cybersecurity vulnerabilities identified for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers.

Previous Article
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer
FDA approves first treatment option specifically for patients with epithelioid sarcoma, a rare soft tissue cancer

FDA granted accelerated approval to Tazverik (tazemetostat) for the treatment of adults and pediatric patie...

Next Article
FDA approves first treatment for thyroid eye disease
FDA approves first treatment for thyroid eye disease

FDA approved Tepezza for the treatment of adults with thyroid eye disease. Today’s approval represents the ...